<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Document</title>
</head>
<body>
  <h1>第 1 节新冠疫苗怎么打？</h1>
  <p><span class="fw-op  "><span>【</span></span>每期文稿后附视频<span class=" fw-cl "><span>】</span></span>欢迎来到新冠疫苗行业的精讲课<span class=" fw-cl "><span>。</span></span></p>
<p>2020 年以来<span class=" fw-cl "><span>，</span></span>新冠疫苗的研发速度如此之快<span class=" fw-cl "><span>，</span></span>让原本黯淡的全球抗疫增添了一个可喜的希望之源<span class=" fw-cl "><span>。</span></span></p>
<p>许多人认为<span class=" fw-cl "><span>，</span></span>疫苗的问世是全球疫情的转折点<span class=" fw-cl "><span>，</span></span>既然疫苗来了<span class=" fw-cl "><span>，</span></span>那么疫情的结束或许指日可待了<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>但现实并非如此简单<span class=" fw-cl "><span>，</span></span>打开手机<span class=" fw-cl "><span>，</span></span>你会发现关于疫苗的消息铺天盖地<span class=" fw-cl "><span>，</span></span>专家观点莫衷一是<span class=" fw-cl "><span>，</span></span>厂家都在王婆卖瓜<span class=" fw-cl "><span>，</span></span>公众误解也很大<span class=" fw-cl "><span>。</span></span></p>
<p>所以我们特别希望通过一个系列<span class=" fw-cl "><span>，</span></span>打消大家对疫苗的疑虑<span class=" fw-cl "><span>，</span></span>同时又能洞察其中的产业逻辑和投资机会<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>首先<span class=" fw-cl "><span>，</span></span>新冠疫苗作为生物技术行业<span class=" fw-cl "><span>，</span></span>供需分析不重要<span class=" fw-cl "><span>，</span></span>产业链不重要<span class=" fw-cl "><span>，</span></span>老板行不行也不重要<span class=" fw-cl "><span>，</span></span><strong>我们重点应该看的是产品线和核心技术平台<span class=" fw-cl "><span>。</span></span></strong></p>
<p>所以这个系列相对来说会打破投学苑原有的课程结构<span class=" fw-cl "><span>，</span></span>我们会从科普向和几种技术路径作为线索展开<span class=" fw-cl "><span>。</span></span>至于上市公司<span class=" fw-cl "><span>，</span></span>我们都会放在这些具体的技术路径之中<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>其次所有的生物医药类的内容<span class=" fw-cl "><span>，</span></span>都有很高的认知门槛<span class=" fw-cl "><span>。</span></span></p>
<p>我们本期的制作人是王佳悦<span class=" fw-cl "><span>，</span></span>他拥有十年以上的生物医药投研经验<span class=" fw-cl "><span>，</span></span>非常资深<span class=" fw-cl "><span>，</span></span>平时和我讲点医药知识<span class=" fw-cl "><span>，</span></span>我都要消化很久<span class=" fw-cl "><span>。</span></span>所以这个系列课我们准备的时间特别久<span class=" fw-cl "><span>，</span></span>就是希望尽可能的把这些知识点幼儿园化<span class=" fw-cl "><span>，</span></span>让大家充分理解吸收<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>好了<span class=" fw-cl "><span>，</span></span>接下来就先进入我们的第一章<span class=" fw-cl "><span>：</span></span>新冠疫苗怎么打<span class=" fw-cl "><span>？</span></span>&nbsp;</p>
<p>不管你炒不炒疫苗股<span class=" fw-cl "><span>，</span></span>疫苗本身肯定是要打的<span class=" fw-cl "><span>。</span></span> 关于怎么打新冠疫苗<span class=" fw-cl "><span>，</span></span>我们的建议有三条<span class=" fw-cl "><span>：</span></span>&nbsp;</p>
<p>1<span class=" fw-cl "><span>、</span></span>晚打不如早打&nbsp;</p>
<p>2<span class=" fw-cl "><span>、</span></span>有什么打什么&nbsp;</p>
<p>3<span class=" fw-cl "><span>、</span></span>打完还要再打&nbsp;</p>
<p><strong>先说第一点<span class=" fw-cl "><span>，</span></span>晚打不如早打<span class=" fw-cl "><span>。</span></span></strong>&nbsp;</p>
<p>从全球范围内来看<span class=" fw-cl "><span>，</span></span>新冠病毒已经 72 变<span class=" fw-cl "><span>，</span></span>而且还展示了人传兽再传人的特异功能<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>抗疫已经从歼灭战转向了持久战<span class=" fw-cl "><span>。</span></span>而这场战争中最为有效的武器就是疫苗<span class=" fw-cl "><span>，</span></span>而每一个接种疫苗的普通人<span class=" fw-cl "><span>，</span></span>都是战士<span class=" fw-cl "><span>。</span></span>就如同在家隔离是战斗一样<span class=" fw-cl "><span>，</span></span>接种疫苗也是战斗<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>更重要的是<span class=" fw-cl "><span>，</span></span>印度和巴西的例子告诉我们<span class=" fw-cl "><span>，</span></span>在高速变异的新冠病毒面前<span class=" fw-cl "><span>，</span></span>不存在自然的<span class="fw-op  "><span>「</span></span>群体免疫<span class=" fw-cl fw--collapsed"><span>」</span></span><span class=" fw-cl "><span>，</span></span>无论抗体检出率是 66% 还是 76%<span class=" fw-cl "><span>，</span></span>在大自然的鬼斧神工面前都败下阵来<span class=" fw-cl "><span>，</span></span>所以等等党是没有意义的<span class=" fw-cl "><span>，</span></span>你还真等着居委会打疫苗送手机不成<span class=" fw-cl "><span>？</span></span></p>
<p>而接种疫苗形成免疫屏障<span class=" fw-cl "><span>，</span></span>却能够极大的遏制疫情的传播<span class=" fw-cl "><span>。</span></span></p>
<p>总结一下<span class=" fw-cl "><span>，</span></span>我们防疫打了大胜仗固然可喜可贺<span class=" fw-cl "><span>，</span></span>但要避免从<span class="fw-op  "><span>「</span></span>防疫高地<span class=" fw-cl "><span>」</span></span>变为<span class="fw-op  "><span>「</span></span>免疫洼地<span class=" fw-cl fw--collapsed"><span>」</span></span><span class=" fw-cl "><span>，</span></span>就必须抓住窗口期<span class=" fw-cl "><span>，</span></span>加快推进疫苗接种<span class=" fw-cl "><span>，</span></span>确保我们来之不易的防疫成果<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p><strong>第二点<span class=" fw-cl "><span>，</span></span>有什么打什么<span class=" fw-cl "><span>。</span></span></strong>评价一个疫苗好不好<span class=" fw-cl "><span>，</span></span>大致可以从可及性<span class=" fw-cl "><span>，</span></span>安全性<span class=" fw-cl "><span>，</span></span>和有效性三个维度来看<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p><strong>可及性</strong>非常简单<span class=" fw-cl "><span>，</span></span>就是你打不打得到<span class=" fw-cl "><span>，</span></span>不要以为这是一件很简单的事情<span class=" fw-cl "><span>，</span></span>事实上<span class=" fw-cl "><span>，</span></span>能海量供给疫苗<span class=" fw-cl "><span>，</span></span>并提供多种选择的国家并不多<span class=" fw-cl "><span>。</span></span></p>
<p>世卫组织在 5 月 5 号做了一个统计<span class=" fw-cl "><span>，</span></span>全球已接种超过 11 亿剂新冠疫苗<span class=" fw-cl "><span>，</span></span>但其中 80% 以上是在高收入和中高收入国家<span class=" fw-cl "><span>，</span></span>而低收入国家接种率只有 0.3%<span class=" fw-cl "><span>，</span></span>而只有一个国家实现了 70%-80% 的接种率<span class=" fw-cl "><span>，</span></span>才能完成群体免疫<span class=" fw-cl "><span>。</span></span>所以打得到比一切都重要<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>而现在<span class=" fw-cl "><span>，</span></span>我国打得到的有 6 种新冠疫苗<span class=" fw-cl "><span>，</span></span>有 3 种剂型的针剂<span class=" fw-cl "><span>。</span></span>北京所<span class=" fw-cl "><span>、</span></span>武汉所<span class=" fw-cl "><span>、</span></span>科兴中维和康泰<span class=" fw-cl "><span>，</span></span>这四种都是灭活疫苗<span class=" fw-cl "><span>，</span></span>需要打 2 针<span class=" fw-cl "><span>。</span></span></p>
<p>走腺病毒载体路线的康希诺<span class=" fw-cl "><span>，</span></span>只需要打 1 针<span class=" fw-cl "><span>，</span></span>最后是重组蛋白的智飞生物<span class=" fw-cl "><span>，</span></span>需要打 3 针<span class=" fw-cl "><span>。</span></span>国内企业自研和代理的 mRNA 疫苗<span class=" fw-cl "><span>，</span></span>很快也将陆续上市<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>大家可以像点菜一样选疫苗打<span class=" fw-cl "><span>，</span></span>可以说的上是一种幸福的烦恼了<span class=" fw-cl "><span>。</span></span>那在可及性充分的情况下<span class=" fw-cl "><span>，</span></span>我们如何找到安全可靠的疫苗呢<span class=" fw-cl "><span>？</span></span>&nbsp;</p>
<p>我们看一下<strong>安全性</strong><span class=" fw-cl "><span>，</span></span>很多人会觉得新冠疫苗的研发太快了<span class=" fw-cl "><span>，</span></span>尤其是 mRNA 疫苗<span class=" fw-cl "><span>，</span></span>更是一种全新的技术<span class=" fw-cl "><span>，</span></span>会不会不够安全<span class=" fw-cl "><span>。</span></span></p>
<p>但新冠疫苗的接种人次已经超过 10 亿<span class=" fw-cl "><span>，</span></span>主流的疫苗品种接种人次也是都以亿为单位<span class=" fw-cl "><span>。</span></span>在如此大规模的接种情况下<span class=" fw-cl "><span>，</span></span>如果疫苗的安全性存在问题<span class=" fw-cl "><span>，</span></span>是不可能被隐瞒的<span class=" fw-cl "><span>。</span></span></p>
<p>比如阿斯利康和强生的疫苗<span class=" fw-cl "><span>，</span></span>因为有极小概率会诱发血栓<span class=" fw-cl "><span>，</span></span>就曾被多国停用<span class=" fw-cl "><span>。</span></span>但后来监管部门审查过后<span class=" fw-cl "><span>，</span></span>认为诱发血栓概率不到十万分之一<span class=" fw-cl "><span>。</span></span>疫苗还是<span class="fw-op  "><span>「</span></span>收益大于风险<span class=" fw-cl "><span>」</span></span>的<span class=" fw-cl "><span>，</span></span>就又恢复使用了<span class=" fw-cl "><span>。</span></span></p>
<p>大家可以看下主流新冠疫苗的不良事件报告率<span class=" fw-cl "><span>，</span></span>我国的几款疫苗安全性都是非常高的<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>可以说<span class=" fw-cl "><span>，</span></span>如果仅仅从安全性这个角度看<span class=" fw-cl "><span>，</span></span>灭活这个路线<span class=" fw-cl "><span>，</span></span>比 mRNA 和腺病毒载体这两种疫苗更强<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>说完了安全性<span class=" fw-cl "><span>，</span></span>我们再来看<strong>有效性</strong><span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>大家看新闻的时候<span class=" fw-cl "><span>，</span></span>经常听到有效率和保护率这些名词<span class=" fw-cl "><span>，</span></span>可能会有些疑惑<span class=" fw-cl "><span>。</span></span>实际上<span class=" fw-cl "><span>，</span></span>疫苗的有效率和保护率是同一个意思<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>单纯从保护率看<span class=" fw-cl "><span>，</span></span>莫德纳和 BioNTech 的 mRNA 疫苗<span class=" fw-cl "><span>，</span></span>在临床试验和真实世界的研究中<span class=" fw-cl "><span>，</span></span>都显示了极高的保护率<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>而相比于 mRNA 疫苗高达 95% 的有效率<span class=" fw-cl "><span>，</span></span>大家都觉得其他类型疫苗的有效率不够高<span class=" fw-cl "><span>。</span></span></p>
<p>比如美国底特律市的市长就曾经拒绝了强生的新冠疫苗<span class=" fw-cl "><span>，</span></span>觉得 66% 的有效率不香<span class=" fw-cl "><span>。</span></span>说我们不要二流疫苗<span class=" fw-cl "><span>，</span></span>要打就打最好的<span class=" fw-cl "><span>，</span></span>如果你只盯着有效率这个数字看<span class=" fw-cl "><span>，</span></span>或许你会同意他的看法<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>但事实上<span class=" fw-cl "><span>，</span></span>有效率的绝对数字并没有那么重要<span class=" fw-cl "><span>。</span></span>要理解有效率和疫苗效果之间的关系<span class=" fw-cl "><span>，</span></span>你先要知道<strong>有效率</strong>是怎么来的<span class=" fw-cl "><span>？</span></span>&nbsp;</p>
<p>疫苗的有效率是从大型临床试验中计算出来的<span class=" fw-cl "><span>。</span></span>疫苗的三期临床试验需要上万名志愿者<span class=" fw-cl "><span>。</span></span></p>
<p>这些勇士被随机分成两组<span class=" fw-cl "><span>，</span></span>一组注射疫苗<span class=" fw-cl "><span>，</span></span>一组注射安慰剂<span class=" fw-cl "><span>，</span></span>无论是科学家还是志愿者都不知道自己被注射了啥<span class=" fw-cl "><span>，</span></span>这就是<span class="fw-op  "><span>「</span></span>双盲试验<span class=" fw-cl fw--collapsed"><span>」</span></span><span class=" fw-cl "><span>。</span></span></p>
<p>然后志愿者们正常生活<span class=" fw-cl "><span>，</span></span>直到他们中的一些人确认感染了新冠病毒<span class=" fw-cl "><span>，</span></span>达到了试验设计的临床终点<span class=" fw-cl "><span>，</span></span>再进行揭盲<span class=" fw-cl "><span>。</span></span></p>
<p>比如 BioNTech 的 mRNA 疫苗<span class=" fw-cl "><span>，</span></span>在美国做了 43000 例的试验<span class=" fw-cl "><span>，</span></span>临床终点是 170 人感染新冠病毒<span class=" fw-cl "><span>。</span></span>这 170 人在两组之间的分布决定了疫苗的有效率<span class=" fw-cl "><span>。</span></span></p>
<p>比如两组都是 85 人<span class=" fw-cl "><span>，</span></span>疫苗的有效率就是 0<span class=" fw-cl "><span>，</span></span>170 人都是安慰剂组<span class=" fw-cl "><span>，</span></span>疫苗的有效率就是 100%<span class=" fw-cl "><span>。</span></span>最后的结果是 162<span class=" fw-cl "><span>：</span></span>8<span class=" fw-cl "><span>，</span></span>算下来疫苗的有效率是 95%<span class=" fw-cl "><span>。</span></span></p>
<p>所以疫苗有效率<span class=" fw-cl "><span>，</span></span>是指针对个人而言<span class=" fw-cl "><span>，</span></span>接种疫苗后再接触病毒的话<span class=" fw-cl "><span>，</span></span>感染的几率下降了 95%<span class=" fw-cl "><span>。</span></span></p>
<p>听到这里你是不是有点疑惑<span class=" fw-cl "><span>，</span></span>这么说起来 66% 的有效率的确是不香啊<span class=" fw-cl "><span>。</span></span>但实际上<span class=" fw-cl "><span>，</span></span>每个疫苗进行临床试验的时间和地点都不尽相同<span class=" fw-cl "><span>。</span></span>它们面对的病毒也不相同<span class=" fw-cl "><span>。</span></span></p>
<p>强生疫苗和科兴疫苗在巴西都遇到了变种病毒的大爆发<span class=" fw-cl "><span>，</span></span>这极大的影响了它们的有效率<span class=" fw-cl "><span>，</span></span>但即使如此<span class=" fw-cl "><span>，</span></span>它们也都达到了 WHO 提出的 50% 的及格线<span class=" fw-cl "><span>。</span></span></p>
<p>很多人不知道<span class=" fw-cl "><span>，</span></span>我们使用了几十年的流感疫苗<span class=" fw-cl "><span>，</span></span>其实大部分年份的真实有效率都不到 50%<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>如果我们要真的比较两款疫苗的优劣<span class=" fw-cl "><span>，</span></span>那么在临床上就要做头对头的试验<span class=" fw-cl "><span>，</span></span>也就是把它们放在同样的时间和空间内做双盲试验<span class=" fw-cl "><span>，</span></span>这样得出来的数据才有说服力<span class=" fw-cl "><span>。</span></span></p>
<p>而现在新冠疫苗的有效率<span class=" fw-cl "><span>，</span></span>只是它们上市之前必须过的一道<span class="fw-op  "><span>「</span></span>铁门槛<span class=" fw-cl fw--collapsed"><span>」</span></span><span class=" fw-cl "><span>，</span></span>而且在真实世界的使用中<span class=" fw-cl "><span>，</span></span>目前所有获批上市的疫苗都体现了自身的价值<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>在临床试验中<span class=" fw-cl "><span>，</span></span>这些疫苗能够 100% 避免感染者发展为重症甚至死亡<span class=" fw-cl "><span>。</span></span>而在真实世界的数据统计中<span class=" fw-cl "><span>，</span></span>所有的疫苗也都展示了足够的保护力<span class=" fw-cl "><span>。</span></span></p>
<p>所以<span class=" fw-cl "><span>，</span></span>最好的疫苗就是你现在能打到的疫苗<span class=" fw-cl "><span>。</span></span>而每注射一针疫苗<span class=" fw-cl "><span>，</span></span>我们离战胜新冠疫情就更近了一步<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>最后我们说一下大家最关心的问题<span class=" fw-cl "><span>，</span></span>未来疫苗要怎么打<span class=" fw-cl "><span>？</span></span>&nbsp;</p>
<p>目前看来<span class=" fw-cl "><span>，</span></span>还要打新冠疫苗加强针是大概率事件<span class=" fw-cl "><span>，</span></span>现在很多科研机构和疫苗厂商都在研究测试新冠疫苗加强针的接种方式<span class=" fw-cl "><span>。</span></span></p>
<p>是否要打加强针<span class=" fw-cl "><span>，</span></span>其实取决于两个因素<span class=" fw-cl "><span>。</span></span></p>
<p><strong>第一个就是病毒突变<span class=" fw-cl "><span>。</span></span>&nbsp;</strong></p>
<p>新冠病毒基因组有 3 万个碱基对<span class=" fw-cl "><span>，</span></span>是目前可以感染人类的最长的病毒<span class=" fw-cl "><span>。</span></span></p>
<p>有数据表明新冠病毒平均每一次传播会发生一个突变<span class=" fw-cl "><span>，</span></span>所以新冠病毒的突变是时时刻刻在发生的<span class=" fw-cl "><span>，</span></span>会不停的有新的亚型<span class="fw-op  "><span>「</span></span>变<span class=" fw-cl "><span>」</span></span>出来<span class=" fw-cl "><span>。</span></span>尤其在疫苗的压力下<span class=" fw-cl "><span>，</span></span>新冠病毒将会定向突变<span class=" fw-cl "><span>，</span></span>变得更加<span class="fw-op  "><span>「</span></span>狡猾<span class=" fw-cl fw--collapsed"><span>」</span></span><span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>比如之前的广州疫情<span class=" fw-cl "><span>，</span></span>来捣乱的病毒就是印度变异株<span class=" fw-cl "><span>。</span></span>它病例有四大特点<span class=" fw-cl "><span>：</span></span>一是感染者普遍病毒载量高<span class=" fw-cl "><span>，</span></span>随之带来的就是另外两大特点——第二传播能力强<span class=" fw-cl "><span>，</span></span>第三潜伏期非常短<span class=" fw-cl "><span>，</span></span>第四个特点就是核酸转阴时间长<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>而在这次疫情中<span class=" fw-cl "><span>，</span></span>发现有 4 例患者注射了第一针新冠疫苗<span class=" fw-cl "><span>，</span></span>还没来得及打第二针<span class=" fw-cl "><span>，</span></span>就被感染了<span class=" fw-cl "><span>。</span></span></p>
<p>但好在<span class=" fw-cl "><span>，</span></span>只要是接种了疫苗<span class=" fw-cl "><span>，</span></span>哪怕没有完成两针的接种<span class=" fw-cl "><span>，</span></span>基本病情都不重<span class=" fw-cl "><span>，</span></span>可见病毒变异也没那么可怕<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p><strong>第二个就是新冠疫苗在体内的免疫反应到底能持续多长时间<span class=" fw-cl "><span>。</span></span></strong></p>
<p>现在得到的数据是 6-9 个月有效<span class=" fw-cl "><span>，</span></span>能否持续 1 年还没有数据<span class=" fw-cl "><span>。</span></span></p>
<p>但从目前的情况来看<span class=" fw-cl "><span>，</span></span> 新冠病毒成为<span class="fw-op  "><span>「</span></span>超级流感<span class=" fw-cl "><span>」</span></span>长期共存的可能性越来越大<span class=" fw-cl "><span>。</span></span>虽然大家内心里对打针都有着本能的抗拒<span class=" fw-cl "><span>，</span></span>但为了更好的保护自己和身边的人<span class=" fw-cl "><span>，</span></span>该打的针一针都不能少<span class=" fw-cl "><span>。</span></span></p>
<p>好了<span class=" fw-cl "><span>，</span></span>第一讲就到这里<span class=" fw-cl "><span>。</span></span>总结一下<span class=" fw-cl "><span>，</span></span>本期主要是讲了新冠疫苗接种的三原则<span class=" fw-cl "><span>：</span></span>晚打不如早打<span class=" fw-cl "><span>，</span></span>有什么打什么<span class=" fw-cl "><span>，</span></span>打了还要再打<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>特别需要提醒大家的是<span class=" fw-cl "><span>，</span></span>疫苗的有效率并不是衡量疫苗好坏的唯一标准<span class=" fw-cl "><span>。</span></span>当前获批上市的新冠疫苗都展示了足够的保护能力<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>再后面几讲<span class=" fw-cl "><span>，</span></span>我们会对各类新冠疫苗做一个简要的分析<span class=" fw-cl "><span>。</span></span>包括灭活疫苗<span class=" fw-cl "><span>、</span></span>mRNA 疫苗以及腺病毒载体疫苗等主要路线<span class=" fw-cl "><span>，</span></span>也会对参与其中的上市公司进行分析<span class=" fw-cl "><span>，</span></span>希望能够对大家的投资有所帮助<span class=" fw-cl "><span>。</span></span></p>
<div class="customizeRender" data-tag="video" data-resource-id="1481590766975320064" data-is-green="false" data-add-head-tail="true" data-cover-url=""></div>
<p><br></p><p><span style="display:block;font-size: 13px;opacity:0.5;transform:translateY(-20px);">备案号:YXX12lZRw44cPoe3kdsgdE9</span></p>
</body>
</html>